Transport and binding of tumor necrosis factor-? in articular cartilage depend on its quaternary structure.
Ontology highlight
ABSTRACT: The effect of tumor necrosis factor-? (TNF?) on cartilage matrix degradation is mediated by its transport and binding within the extracellular matrix (ECM) of the tissue, which mediates availability to cell receptors. Since the bioactive form of TNF? is a homotrimer of monomeric subunits, conversion between trimeric and monomeric forms during intratissue transport may affect binding to ECM and, thereby, bioactivity within cartilage. We studied the transport and binding of TNF? in cartilage, considering the quaternary structure of this cytokine. Competitive binding assays showed significant binding of TNF? in cartilage tissue, leading to an enhanced uptake. However, studies in which TNF? was cross-linked to remain in the trimeric form revealed that the binding of trimeric TNF? was negligible. Thus, binding of TNF? to ECM was associated with the monomeric form. Binding of TNF? was not disrupted by pre-treating cartilage tissue with trypsin, which removes proteoglycans and glycoproteins but leaves the collagen network intact. Therefore, proteoglycan loss during osteoarthritis should only alter the passive diffusion of TNF? but not its binding interaction with the remaining matrix. Our results suggest that matrix binding and trimer-monomer conversion of TNF? both play crucial roles in regulating the accessibility of bioactive TNF? within cartilage.
SUBMITTER: Byun S
PROVIDER: S-EPMC3900242 | biostudies-literature | 2013 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA